Tucson, AZ, United States of America

Tally M Largent-Milnes

This inventor holds 1 USPTO granted patent. Top assignee: The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tally M Largent-Milnes. Retrieved from https://idiyas.com/inventor/tally-m-largent-milnes

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Tally M Largent-Milnes: Innovator in Headache Treatment

Introduction

Tally M Largent-Milnes is a notable inventor based in Tucson, AZ (US). He has made significant contributions to the field of headache treatment through his innovative research and development. His work focuses on enhancing the activity of 2-arachidonyl glycerol, which has implications for preventing and treating headaches.

Latest Patents

Largent-Milnes holds a patent titled "Compositions and Methods for Preventing and Treating Headache Through Enhancing 2-Arachidonyl Glycerol Activity." This patent represents a breakthrough in understanding how certain compounds can alleviate headache symptoms.

Career Highlights

He is currently associated with the United States of America, as Represented by the Secretary, Department of Health and Human Services. His role in this organization allows him to contribute to public health initiatives and advance research in headache treatment.

Collaborations

Largent-Milnes has collaborated with notable colleagues, including Erika Liktor-Busa and Todd W Vanderah. These partnerships enhance the research efforts and broaden the impact of their findings in the medical community.

Conclusion

Tally M Largent-Milnes is a pioneering inventor whose work in headache treatment is making a difference in the lives of many. His innovative approaches and collaborations continue to push the boundaries of medical research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…